...
首页> 外文期刊>The Annals of Thoracic Surgery: Official Journal of the Society of Thoracic Surgeons and the Southern Thoracic Surgical Association >The Effect of a High Dose of Atorvastatin on the Occurrence of Atrial Fibrillation After Coronary Artery Bypass Grafting
【24h】

The Effect of a High Dose of Atorvastatin on the Occurrence of Atrial Fibrillation After Coronary Artery Bypass Grafting

机译:大剂量阿托伐他汀对冠状动脉搭桥术后房颤发生的影响

获取原文

摘要

PatientsMeasurementsStatisticsResultsRecent studies have suggested that statins reduce the incidence of atrial fibrillation (AF) after cardiac operations. Statin therapy at intensive doses, however, has yet to be thoroughly investigated.MethodsWe retrospectively studied 1,839 consecutive patients (1,177 men [73.2%]) who underwent isolated coronary artery bypass grafting and had no history of previous AF, pacemaker implantation, or antiarrhythmic medication. Data recorded included the atorvastatin dose during hospitalization, demographic, echocardiographic, and angiographic data, medical history, drug treatment, and procedural characteristics. Continuous telemonitoring during the first 72 postoperative hours assessed for AF, which was defined as episodes lasting more than 5 minutes. The dose-related effect of atorvastatin on postoperative AF was investigated by logistic analysis in 1,607 patients: 75 (4.7%) did not receive atorvastatin vs 1,047 (65.1%) and 485 (30.2%) who received 40 mg/d or 80 mg/d, respectively, for at least 3 days before the operation.ResultsThe study population was a mean age of 60.6 ± 9.5 years. Multivariate logistic regression demonstrated that a lack of atorvastatin pretreatment along with older age, enlarged left atrium, and male sex, and not taking β-blockers, tended to be associated with an increased risk of postoperative AF. There was no significant difference between the effect of a higher (80 mg/d) and a lower dose (40 mg/d) in reducing postoperative AF.ConclusionsAtorvastatin pretreatment significantly reduced the occurrence of AF after bypass grafting; nonetheless, the difference between the beneficial effects of intensive and routine atorvastatin treatments on postoperative AF was not significant.CTSNet classification:24Adult Cardiac SurgeryThe Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS member or an individual non-member subscription to the journal.Atrial fibrillation (AF) is a common complication after cardiothoracic operations [
机译:患者测量统计结果最近的研究表明,他汀类药物可减少心脏手术后房颤(AF)的发生。方法我们回顾性研究了1,839例行连续冠状动脉搭桥术且无先前房颤,起搏器植入或抗心律失常药物史的连续患者(1,177例男性,占73.2%)。 。记录的数据包括住院期间的阿托伐他汀剂量,人口统计学,超声心动图和血管造影数据,病史,药物治疗和程序特征。在术后的前72小时内进行连续的远程监护以评估房颤,这被定义为发作持续超过5分钟。通过逻辑分析在1,607名患者中研究了阿托伐他汀对术后房颤的剂量相关作用:75名(4.7%)未接受阿托伐他汀与1,047名(65.1%)和485名(30.2%)接受40 mg / d或80 mg / d d分别在手术前至少3天。结果研究人群的平均年龄为60.6±9.5岁。多元逻辑回归分析表明,缺乏阿托伐他汀预处理,年龄较大,左心房增大和男性,且未服用β受体阻滞剂,往往会增加术后房颤的风险。较高的剂量(80 mg / d)和较低的剂量(40 mg / d)对降低术后房颤的影响之间无显着差异。结论阿托伐他汀预处理可显着减少旁路移植后房颤的发生;尽管如此,强化和常规阿托伐他汀治疗对术后房颤的有益作用之间的差异并不显着。CTSNet分类:24成人心脏外科手术胸外科CME程序年鉴位于http://cme.ctsnetjournals.org。要进行与本文相关的CME活动,您必须具有STS会员或单独的非会员订阅。心房纤颤(AF)是心胸外科手术后的常见并发症[

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号